Homepage
Medication Guide
Indications for Repotrectinib (Augtyro)
Repotrectinib (Augtyro) is an innovative kinase inhibitor that received its first approval from the U.S. Food and Drug Administration (FDA) in 2023. As a next-generation targeted therapy, repotrectini...
512
Friday, November 14th, 2025, 09:48
How to Purchase Repotrectinib (Augtyro)
Repotrectinib (Augtyro) is a next-generation kinase inhibitor and an important targeted medication for the treatment of ROS1-positive non-small cell lung cancer (NSCLC) and NTRK gene fusion-positive s...
508
Thursday, November 13th, 2025, 13:21
What Are the Side Effects of Rasagiline (Azilect)?
Rasagiline (Azilect) is a selective and irreversible monoamine oxidase type B (MAO-B) inhibitor, approved for the treatment of Parkinson's disease. While this medication effectively improves motor...
508
Thursday, November 13th, 2025, 13:16
Precautions for Using Rasagiline (Azilect)
Rasagiline (Azilect) is one of the important medications currently used for the treatment of Parkinson's disease. As a monoamine oxidase (MAO) inhibitor, this drug carries specific risks such as h...
510
Thursday, November 13th, 2025, 13:09
How to Use Rasagiline (Azilect)
Rasagiline (Azilect) is a selective and irreversible monoamine oxidase type B (MAO-B) inhibitor, which was first approved for marketing in the United States in 2006. This medication is indicated for t...
506
Thursday, November 13th, 2025, 11:49
Indications for Rasagiline (Azilect)
Rasagiline (Azilect) is a selective and irreversible monoamine oxidase type B (MAO-B) inhibitor. Since its approval by the U.S. FDA in 2006, it has become an important treatment option for Parkinson&#...
506
Thursday, November 13th, 2025, 11:37
How to Purchase Rasagiline (Azilect)
Rasagiline (Azilect) is a selective and irreversible monoamine oxidase type B (MAO-B) inhibitor, and an important medication for the treatment of Parkinson's disease.How to Purchase Rasagiline (Az...
508
Thursday, November 13th, 2025, 11:30
What Are the Side Effects of Resmetirom (Rezdiffra)?
Resmetirom (Rezdiffra) is the first thyroid hormone receptor-beta agonist approved by the U.S. FDA in 2024 through the accelerated approval pathway for the treatment of non-cirrhotic non-alcoholic ste...
508
Thursday, November 13th, 2025, 11:25
Precautions for Using Resmetirom (Rezdiffra)
Resmetirom (Rezdiffra) is a thyroid hormone receptor-beta (THR-β) agonist and the first targeted drug approved for the treatment of non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to ...
512
Thursday, November 13th, 2025, 11:18
How to Use Resmetirom (Rezdiffra)
Resmetirom (Rezdiffra) is a thyroid hormone receptor-beta agonist approved for marketing by the U.S. FDA in 2024. When used in combination with diet and exercise, this medication is indicated for the ...
510
Thursday, November 13th, 2025, 11:16
65 / 214
2139 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved